Vaccine Clinical Trials
Here are the 6 most popular medical studies for vaccine
Cancer Vaccine
Immunization Response for Childhood Cancer Survivors
Recruiting2 awardsPhase 2
New York, New York
This trial will study how well cancer patients' bodies respond to new immunizations. The goal is to see how well the immunizations protect patients and to find the best way to re-immunize people after cancer treatments.
Cancer Vaccine
Melanoma Vaccine for Melanoma
Recruiting1 awardPhase 1 & 2
Cleveland, Ohio
This trial will test a new cancer vaccine made of 6MHP and a mutated neoantigen peptide combined with two different adjuvants. The vaccine will be given to people with advanced melanoma to see if it is safe and if it can create an immune response against the cancer.
Cancer Vaccine
DNA Vaccines + Pembrolizumab for Metastatic Prostate Cancer
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial will evaluate the use of one versus two DNA vaccines to treat prostate cancer that has spread and is no longer responding to hormone therapy. The hypothesis is that delivering two vaccines with a drug that blocks PD-1 will increase the percentage of patients experiencing an anti-tumor effect.
Popular filter options for vaccine trials
Clinical Trials With No Placebo
View 27 medical studies that do not have a placebo group.
IDO1 Inhibitor
Combination Immunotherapy for Pancreatic Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial will enroll patients with metastatic pancreatic cancer who have progressed on prior chemotherapy. Patients will receive a combination of epacadostat, pembrolizumab, and either cyclophosphamide/GVAX pancreas vaccine or CRS-207. The primary objectives of the study are to determine the recommended dose of epacadostat and to assess the survival of patients in both treatment groups.
Cancer Vaccine
Dendritic Cell Vaccine for Brain Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing which combination of immunotherapy vaccines is most effective in patients with malignant glioma, a type of brain cancer. Dendritic cells, which present cell identifiers to the immune system, are isolated from the subject's blood and pulsed with tumor lysate, a combination that is hoped will stimulate the immune system to recognize and destroy the patient's brain tumor. The pulsed dendritic cells are then injected back into the patient, with or without adjuvant imiquimod or poly ICLC.
Cancer Vaccine
Tumor Cell Vaccine + Cytoxan for Neuroblastoma
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing an experimental treatment for neuroblastoma, which is a solid tumor that is the second most common cancer in children. The treatment consists of a series of immunizations using a tumor vaccine, combined with low-dose chemotherapy taken by mouth on a daily basis. The hope is that the vaccine will cause the immune system to recognize and kill more types of neuroblastoma tumors. Additionally, the immunizations will be combined with daily low dose chemotherapy.
View More Vaccine Trials
See another 11 medical studies focused on vaccine.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.